A systems biology framework identifies molecular underpinnings of coronary heart disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 6, 2013, Pages 1427-1434

  Huan, Tianxiao ^a,b   Zhang, Bin ^c,d,f   Wang, Zhi ^e,g   Joehanes, Roby ^a,b,h   Zhu, Jun ^c,d,f   Johnson, Andrew D ^a,b   Ying, Saixia ^h   Munson, Peter J ^h   Raghavachari, Nalini ^b   Wang, Richard ^b   Liu, Poching ^b   Courchesne, Paul ^a   Hwang, Shih Jen ^a   Assimes, Themistocles L ⁱ   McPherson, Ruth ^j   Samani, Nilesh J ^k   Schunkert, Heribert ^c   Meng, Qingying ^l   Suver, Christine ^e   O'Donnell, Christopher J ^b   Derry, Jonathan ^e   Yang, Xia ^l   Levy, Daniel ^a,b   more..

^a FRAMINGHAM HEART STUDY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Department of Genetics and Genomic Sciences ^*  (Germany)

^d Institute of Genomics and Multiscale Biology   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f SAGE BIONETWORKS   (United States)

^g ARIZONA STATE UNIVERSITY   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF OTTAWA   (Canada)

^k UNIVERSITY OF LEICESTER   (United Kingdom)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Coexpression network; Coronary heart disease; Gene expression; Systems biology

Indexed keywords

AGED; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; FEMALE; GENE; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; ION TRANSPORT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMS BIOLOGY;

COEXPRESSION NETWORK; CORONARY HEART DISEASE; GENE EXPRESSION; SYSTEMS BIOLOGY;

AGE DISTRIBUTION; AGED; BAYES THEOREM; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; RISK ASSESSMENT; SEX DISTRIBUTION; SYSTEMS BIOLOGY;

EID: 84879121298     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300112     Document Type: Article

References (39)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095-2128.
2. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell. 2001;104:503-516.
3. Schunkert H, König IR, Kathiresan S, et al; Cardiogenics; CARDIoGRAM Consortium. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333-338.
4. Lotta LA, Peyvandi F. Addressing the complexity of cardiovascular disease by design. Lancet. 2011;377:356-358.
5. Park JH, Wacholder S, Gail MH, Peters U, Jacobs KB, Chanock SJ, Chatterjee N. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet. 2010;42:570-575.
6. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317-325.
7. Sinnaeve PR, Donahue MP, Grass P, Seo D, Vonderscher J, Chibout SD, Kraus WE, Sketch M Jr., Nelson C, Ginsburg GS, Goldschmidt-Clermont PJ, Granger CB. Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease. PLoS One. 2009;4: e7037.
8. Wingrove JA, Daniels SE, Sehnert AJ, Tingley W, Elashoff MR, Rosenberg S, Buellesfeld L, Grube E, Newby LK, Ginsburg GS, Kraus WE. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ Cardiovasc Genet. 2008;1:31-38.
9. Rosenberg S, Elashoff MR, Beineke P, et al PREDICT (Personalized Risk Evaluation and Diagnosis in the Coronary Tree) Investigators. Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients. Ann Intern Med. 2010;153:425-434.
10. Joehanes R, Ying S, Huan T, Johnson AD, Raghavachari N, Wang R, Liu P, Woodhouse KA, Tanriverdi K, Courchesne P, Freedman JE, O'Donnell CJ, Levy D, Munson PJ. Gene expression signatures of coronary heart disease. Arterioscler Thromb Vasc Biol. March 28, 2013. DOI: 10.1161/ATVBAHA.112.301169. http://atvb.ahajournals.org/content/early/2013/03/28/ATVBAHA.112.301169.long. Accessed April 2, 2013.
11. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
12. Zhong H, Yang X, Kaplan LM, Molony C, Schadt EE. Integrating pathway analysis and genetics of gene expression for genome-wide association studies. Am J Hum Genet. 2010;86:581-591.
13. Zhong H, Beaulaurier J, Lum PY, et al. Liver and adipose expression associated SNPs are enriched for association to type 2 diabetes. PLoS Genet. 2010;6:-e1000932.
14. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-713.
15. Emilsson V, Thorleifsson G, Zhang B, et al. Genetics of gene expression and its effect on disease. Nature. 2008;452:423-428.
16. Derry JM, Zhong H, Molony C, et al. Identification of genes and networks driving cardiovascular and metabolic phenotypes in a mouse F2 intercross. PLoS One. 2010;5:-e14319.
17. Mishra GR, Suresh M, Kumaran K, et al. Human protein reference database-2006 update. Nucleic Acids Res. 2006;34:D411-D414.
18. Sage AP, Harrison JE, Baker LA, Masters L, Tsiantoulas D, Binder CJ, Mallat Z. Depletion of mature B cells by deletion of BAFF receptor reduces atherosclerosis in ldlr knockout mice. Circulation. 2011; 124:A9224
19. Sage AP, Tsiantoulas D, Baker L, Harrison J, Masters L, Murphy D, Loinard C, Binder CJ, Mallat Z. BAFF receptor deficiency reduces the development of atherosclerosis in mice-brief report. Arterioscler Thromb Vasc Biol. 2012;32:1573-1576.
20. Fretz JA, Nelson T, Xi Y, Adams DJ, Rosen CJ, Horowitz MC. Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse. Endocrinology. 2010;151:1611-1621.
21. Nalls MA, Couper DJ, Tanaka T, et al. Multiple loci are associated with white blood cell phenotypes. PLoS Genet. 2011;7:-e1002113.
22. Huan T, Sivachenko AY, Harrison SH, Chen JY. ProteoLens: a visual analytic tool for multi-scale database-driven biological network data mining. BMC Bioinformatics. 2008;9:S5.
23. Chen Y, Zhu J, Lum PY, et al. Variations in DNA elucidate molecular networks that cause disease. Nature. 2008;452:429-435.
24. Yang X, Deignan JL, Qi H, et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks. Nat Genet. 2009;41:415-423.
25. Yang X, Peterson L, Thieringer R, et al. Identification and validation of genes affecting aortic lesions in mice. J Clin Invest. 2010;120:2414-2422.
26. Hansson GK, Libby P. The immune response in atherosclerosis: a doubleedged sword. Nat Rev Immunol. 2006;6:508-519.
27. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest. 2002;109:745-753.
28. Kyaw T, Tay C, Krishnamurthi S, Kanellakis P, Agrotis A, Tipping P, Bobik A, Toh BH. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res. 2011;109:830-840.
29. Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, Taleb S, Van Vré E, Esposito B, Vilar J, Sirvent J, Van Snick J, Tedgui A, Tedder TF, Mallat Z. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med. 2010;207:1579-1587.
30. Perry HM, McNamara CA. Refining the role of B cells in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32:1548-1549.
31. Newton-Cheh C, Johnson T, Gateva V, et al Wellcome Trust Case Control Consortium. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41:666-676.
32. Adeyemo A, Gerry N, Chen G, Herbert A, Doumatey A, Huang H, Zhou J, Lashley K, Chen Y, Christman M, Rotimi C. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 2009;5:-e1000564.
33. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-687.
34. Speliotes EK, Willer CJ, Berndt SI, et al MAGIC; Procardis Consortium. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937-948.
35. Voight BF, Scott LJ, Steinthorsdottir V, et al; MAGIC investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010;42:579-589.
36. Segrè AV, Groop L, Mootha VK, Daly MJ, Altshuler D; DIAGRAM Consortium; MAGIC investigators. Common inherited variation in mitochondrial genes is not enriched for associations with type 2 diabetes or related glycemic traits. PLoS Genet. 2010;6:-e1001058.
37. Weng L, Macciardi F, Subramanian A, Guffanti G, Potkin SG, Yu Z, Xie X. SNP-based pathway enrichment analysis for genome-wide association studies. BMC Bioinformatics. 2011;12:99.
38. Holden M, Deng S, Wojnowski L, Kulle B. GSEA-SNP: applying gene set enrichment analysis to SNP data from genome-wide association studies. Bioinformatics. 2008;24:2784-2785.
39. Lahoute C, Herbin O, Mallat Z, Tedgui A. Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets. Nat Rev Cardiol. 2011;8:348-358.